学术探索
学术期刊
新闻热点
数据分析
智能评审
立即登录
INITIAL STUDIES ON THE CELLULAR PHARMACOLOGY OF 2',3'-DIDEOXYINOSINE, AN INHIBITOR OF HIV INFECTIVITY
被引:208
作者
:
AHLUWALIA, G
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
AHLUWALIA, G
COONEY, DA
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
COONEY, DA
MITSUYA, H
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
MITSUYA, H
FRIDLAND, A
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
FRIDLAND, A
FLORA, KP
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
FLORA, KP
HAO, Z
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
HAO, Z
DALAL, M
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
DALAL, M
BRODER, S
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
BRODER, S
JOHNS, DG
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
JOHNS, DG
机构
:
[1]
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
[2]
ST JUDE CHILDRENS RES HOSP,DIV BIOCHEM & CLIN PHARMACOL,MEMPHIS,TN 38101
来源
:
BIOCHEMICAL PHARMACOLOGY
|
1987年
/ 36卷
/ 22期
关键词
:
D O I
:
10.1016/0006-2952(87)90440-0
中图分类号
:
R9 [药学];
学科分类号
:
1007 ;
摘要
:
引用
收藏
页码:3797 / 3800
页数:4
相关论文
共 9 条
[1]
ISOLATION OF A T-LYMPHOTROPIC RETROVIRUS FROM A PATIENT AT RISK FOR ACQUIRED IMMUNE-DEFICIENCY SYNDROME (AIDS)
BARRESINOUSSI, F
论文数:
0
引用数:
0
h-index:
0
机构:
HOP CLAUDE BERNARD, CENT VIROL LAB, F-75019 PARIS, FRANCE
BARRESINOUSSI, F
CHERMANN, JC
论文数:
0
引用数:
0
h-index:
0
机构:
HOP CLAUDE BERNARD, CENT VIROL LAB, F-75019 PARIS, FRANCE
CHERMANN, JC
REY, F
论文数:
0
引用数:
0
h-index:
0
机构:
HOP CLAUDE BERNARD, CENT VIROL LAB, F-75019 PARIS, FRANCE
REY, F
NUGEYRE, MT
论文数:
0
引用数:
0
h-index:
0
机构:
HOP CLAUDE BERNARD, CENT VIROL LAB, F-75019 PARIS, FRANCE
NUGEYRE, MT
CHAMARET, S
论文数:
0
引用数:
0
h-index:
0
机构:
HOP CLAUDE BERNARD, CENT VIROL LAB, F-75019 PARIS, FRANCE
CHAMARET, S
GRUEST, J
论文数:
0
引用数:
0
h-index:
0
机构:
HOP CLAUDE BERNARD, CENT VIROL LAB, F-75019 PARIS, FRANCE
GRUEST, J
DAUGUET, C
论文数:
0
引用数:
0
h-index:
0
机构:
HOP CLAUDE BERNARD, CENT VIROL LAB, F-75019 PARIS, FRANCE
DAUGUET, C
AXLERBLIN, C
论文数:
0
引用数:
0
h-index:
0
机构:
HOP CLAUDE BERNARD, CENT VIROL LAB, F-75019 PARIS, FRANCE
AXLERBLIN, C
VEZINETBRUN, F
论文数:
0
引用数:
0
h-index:
0
机构:
HOP CLAUDE BERNARD, CENT VIROL LAB, F-75019 PARIS, FRANCE
VEZINETBRUN, F
ROUZIOUX, C
论文数:
0
引用数:
0
h-index:
0
机构:
HOP CLAUDE BERNARD, CENT VIROL LAB, F-75019 PARIS, FRANCE
ROUZIOUX, C
ROZENBAUM, W
论文数:
0
引用数:
0
h-index:
0
机构:
HOP CLAUDE BERNARD, CENT VIROL LAB, F-75019 PARIS, FRANCE
ROZENBAUM, W
MONTAGNIER, L
论文数:
0
引用数:
0
h-index:
0
机构:
HOP CLAUDE BERNARD, CENT VIROL LAB, F-75019 PARIS, FRANCE
MONTAGNIER, L
[J].
SCIENCE,
1983,
220
(4599)
: 868
-
871
[2]
INITIAL STUDIES ON THE CELLULAR PHARMACOLOGY OF 2',3'-DIDEOXYADENOSINE, AN INHIBITOR OF HTLV-III INFECTIVITY
COONEY, DA
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,DEV THERAPEUT PROGRAM,BETHESDA,MD 20892
COONEY, DA
AHLUWALIA, G
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,DEV THERAPEUT PROGRAM,BETHESDA,MD 20892
AHLUWALIA, G
MITSUYA, H
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,DEV THERAPEUT PROGRAM,BETHESDA,MD 20892
MITSUYA, H
FRIDLAND, A
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,DEV THERAPEUT PROGRAM,BETHESDA,MD 20892
FRIDLAND, A
JOHNSON, M
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,DEV THERAPEUT PROGRAM,BETHESDA,MD 20892
JOHNSON, M
HAO, Z
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,DEV THERAPEUT PROGRAM,BETHESDA,MD 20892
HAO, Z
DALAL, M
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,DEV THERAPEUT PROGRAM,BETHESDA,MD 20892
DALAL, M
BALZARINI, J
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,DEV THERAPEUT PROGRAM,BETHESDA,MD 20892
BALZARINI, J
BRODER, S
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,DEV THERAPEUT PROGRAM,BETHESDA,MD 20892
BRODER, S
JOHNS, DG
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,DEV THERAPEUT PROGRAM,BETHESDA,MD 20892
JOHNS, DG
[J].
BIOCHEMICAL PHARMACOLOGY,
1987,
36
(11)
: 1765
-
1768
[3]
INITIAL STUDIES ON THE CELLULAR PHARMACOLOGY OF 2',3'-DIDEOXYCYTIDINE, AN INHIBITOR OF HTLV-III INFECTIVITY
COONEY, DA
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
COONEY, DA
DALAL, M
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
DALAL, M
MITSUYA, H
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
MITSUYA, H
MCMAHON, JB
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
MCMAHON, JB
NADKARNI, M
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
NADKARNI, M
BALZARINI, J
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
BALZARINI, J
BRODER, S
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
BRODER, S
JOHNS, DG
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
JOHNS, DG
[J].
BIOCHEMICAL PHARMACOLOGY,
1986,
35
(13)
: 2065
-
2068
[4]
DAWSON WH, 1977, J CARB-NUCLEOS-NUCL, V4, P363
[5]
FREQUENT DETECTION AND ISOLATION OF CYTOPATHIC RETROVIRUSES (HTLV-III) FROM PATIENTS WITH AIDS AND AT RISK FOR AIDS
GALLO, RC
论文数:
0
引用数:
0
h-index:
0
机构:
NCI, IMMUNOL BRANCH, BETHESDA, MD 20205 USA
GALLO, RC
SALAHUDDIN, SZ
论文数:
0
引用数:
0
h-index:
0
机构:
NCI, IMMUNOL BRANCH, BETHESDA, MD 20205 USA
SALAHUDDIN, SZ
POPOVIC, M
论文数:
0
引用数:
0
h-index:
0
机构:
NCI, IMMUNOL BRANCH, BETHESDA, MD 20205 USA
POPOVIC, M
SHEARER, GM
论文数:
0
引用数:
0
h-index:
0
机构:
NCI, IMMUNOL BRANCH, BETHESDA, MD 20205 USA
SHEARER, GM
KAPLAN, M
论文数:
0
引用数:
0
h-index:
0
机构:
NCI, IMMUNOL BRANCH, BETHESDA, MD 20205 USA
KAPLAN, M
HAYNES, BF
论文数:
0
引用数:
0
h-index:
0
机构:
NCI, IMMUNOL BRANCH, BETHESDA, MD 20205 USA
HAYNES, BF
PALKER, TJ
论文数:
0
引用数:
0
h-index:
0
机构:
NCI, IMMUNOL BRANCH, BETHESDA, MD 20205 USA
PALKER, TJ
REDFIELD, R
论文数:
0
引用数:
0
h-index:
0
机构:
NCI, IMMUNOL BRANCH, BETHESDA, MD 20205 USA
REDFIELD, R
OLESKE, J
论文数:
0
引用数:
0
h-index:
0
机构:
NCI, IMMUNOL BRANCH, BETHESDA, MD 20205 USA
OLESKE, J
SAFAI, B
论文数:
0
引用数:
0
h-index:
0
机构:
NCI, IMMUNOL BRANCH, BETHESDA, MD 20205 USA
SAFAI, B
WHITE, G
论文数:
0
引用数:
0
h-index:
0
机构:
NCI, IMMUNOL BRANCH, BETHESDA, MD 20205 USA
WHITE, G
FOSTER, P
论文数:
0
引用数:
0
h-index:
0
机构:
NCI, IMMUNOL BRANCH, BETHESDA, MD 20205 USA
FOSTER, P
MARKHAM, PD
论文数:
0
引用数:
0
h-index:
0
机构:
NCI, IMMUNOL BRANCH, BETHESDA, MD 20205 USA
MARKHAM, PD
[J].
SCIENCE,
1984,
224
(4648)
: 500
-
503
[6]
KELLEY JA, IN PRESS DRUG METAB
[7]
INHIBITION OF THE INVITRO INFECTIVITY AND CYTOPATHIC EFFECT OF HUMAN LYMPHOTROPHIC-T VIRUS "TYPE-III/LYMPHADENOPATHY-ASSOCIATED VIRUS (HTLV-III/LAV) BY 2',3'-DIDEOXYNUCLEOSIDES
MITSUYA, H
论文数:
0
引用数:
0
h-index:
0
MITSUYA, H
BRODER, S
论文数:
0
引用数:
0
h-index:
0
BRODER, S
[J].
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA,
1986,
83
(06)
: 1911
-
1915
[8]
THERMAL INACTIVATION AS A MEANS OF INHIBITING SERUM-ASSOCIATED DEAMINATION OF 9-BETA-D-ARABINOFURANOSYLADENINE IN TISSUE-CULTURE MEDIA
SCHWARTZ, PM
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV MICHIGAN, SCH MED, DEPT MICROBIOL, ANN ARBOR, MI 48104 USA
SCHWARTZ, PM
SHIPMAN, C
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV MICHIGAN, SCH MED, DEPT MICROBIOL, ANN ARBOR, MI 48104 USA
SHIPMAN, C
CARLSON, RH
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV MICHIGAN, SCH MED, DEPT MICROBIOL, ANN ARBOR, MI 48104 USA
CARLSON, RH
DRACH, JC
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV MICHIGAN, SCH MED, DEPT MICROBIOL, ANN ARBOR, MI 48104 USA
DRACH, JC
[J].
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY,
1974,
5
(03)
: 337
-
343
[9]
TYAGI AK, 1980, CANCER RES, V40, P4390
←
1
→
共 9 条
[1]
ISOLATION OF A T-LYMPHOTROPIC RETROVIRUS FROM A PATIENT AT RISK FOR ACQUIRED IMMUNE-DEFICIENCY SYNDROME (AIDS)
BARRESINOUSSI, F
论文数:
0
引用数:
0
h-index:
0
机构:
HOP CLAUDE BERNARD, CENT VIROL LAB, F-75019 PARIS, FRANCE
BARRESINOUSSI, F
CHERMANN, JC
论文数:
0
引用数:
0
h-index:
0
机构:
HOP CLAUDE BERNARD, CENT VIROL LAB, F-75019 PARIS, FRANCE
CHERMANN, JC
REY, F
论文数:
0
引用数:
0
h-index:
0
机构:
HOP CLAUDE BERNARD, CENT VIROL LAB, F-75019 PARIS, FRANCE
REY, F
NUGEYRE, MT
论文数:
0
引用数:
0
h-index:
0
机构:
HOP CLAUDE BERNARD, CENT VIROL LAB, F-75019 PARIS, FRANCE
NUGEYRE, MT
CHAMARET, S
论文数:
0
引用数:
0
h-index:
0
机构:
HOP CLAUDE BERNARD, CENT VIROL LAB, F-75019 PARIS, FRANCE
CHAMARET, S
GRUEST, J
论文数:
0
引用数:
0
h-index:
0
机构:
HOP CLAUDE BERNARD, CENT VIROL LAB, F-75019 PARIS, FRANCE
GRUEST, J
DAUGUET, C
论文数:
0
引用数:
0
h-index:
0
机构:
HOP CLAUDE BERNARD, CENT VIROL LAB, F-75019 PARIS, FRANCE
DAUGUET, C
AXLERBLIN, C
论文数:
0
引用数:
0
h-index:
0
机构:
HOP CLAUDE BERNARD, CENT VIROL LAB, F-75019 PARIS, FRANCE
AXLERBLIN, C
VEZINETBRUN, F
论文数:
0
引用数:
0
h-index:
0
机构:
HOP CLAUDE BERNARD, CENT VIROL LAB, F-75019 PARIS, FRANCE
VEZINETBRUN, F
ROUZIOUX, C
论文数:
0
引用数:
0
h-index:
0
机构:
HOP CLAUDE BERNARD, CENT VIROL LAB, F-75019 PARIS, FRANCE
ROUZIOUX, C
ROZENBAUM, W
论文数:
0
引用数:
0
h-index:
0
机构:
HOP CLAUDE BERNARD, CENT VIROL LAB, F-75019 PARIS, FRANCE
ROZENBAUM, W
MONTAGNIER, L
论文数:
0
引用数:
0
h-index:
0
机构:
HOP CLAUDE BERNARD, CENT VIROL LAB, F-75019 PARIS, FRANCE
MONTAGNIER, L
[J].
SCIENCE,
1983,
220
(4599)
: 868
-
871
[2]
INITIAL STUDIES ON THE CELLULAR PHARMACOLOGY OF 2',3'-DIDEOXYADENOSINE, AN INHIBITOR OF HTLV-III INFECTIVITY
COONEY, DA
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,DEV THERAPEUT PROGRAM,BETHESDA,MD 20892
COONEY, DA
AHLUWALIA, G
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,DEV THERAPEUT PROGRAM,BETHESDA,MD 20892
AHLUWALIA, G
MITSUYA, H
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,DEV THERAPEUT PROGRAM,BETHESDA,MD 20892
MITSUYA, H
FRIDLAND, A
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,DEV THERAPEUT PROGRAM,BETHESDA,MD 20892
FRIDLAND, A
JOHNSON, M
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,DEV THERAPEUT PROGRAM,BETHESDA,MD 20892
JOHNSON, M
HAO, Z
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,DEV THERAPEUT PROGRAM,BETHESDA,MD 20892
HAO, Z
DALAL, M
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,DEV THERAPEUT PROGRAM,BETHESDA,MD 20892
DALAL, M
BALZARINI, J
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,DEV THERAPEUT PROGRAM,BETHESDA,MD 20892
BALZARINI, J
BRODER, S
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,DEV THERAPEUT PROGRAM,BETHESDA,MD 20892
BRODER, S
JOHNS, DG
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,DEV THERAPEUT PROGRAM,BETHESDA,MD 20892
JOHNS, DG
[J].
BIOCHEMICAL PHARMACOLOGY,
1987,
36
(11)
: 1765
-
1768
[3]
INITIAL STUDIES ON THE CELLULAR PHARMACOLOGY OF 2',3'-DIDEOXYCYTIDINE, AN INHIBITOR OF HTLV-III INFECTIVITY
COONEY, DA
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
COONEY, DA
DALAL, M
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
DALAL, M
MITSUYA, H
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
MITSUYA, H
MCMAHON, JB
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
MCMAHON, JB
NADKARNI, M
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
NADKARNI, M
BALZARINI, J
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
BALZARINI, J
BRODER, S
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
BRODER, S
JOHNS, DG
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
JOHNS, DG
[J].
BIOCHEMICAL PHARMACOLOGY,
1986,
35
(13)
: 2065
-
2068
[4]
DAWSON WH, 1977, J CARB-NUCLEOS-NUCL, V4, P363
[5]
FREQUENT DETECTION AND ISOLATION OF CYTOPATHIC RETROVIRUSES (HTLV-III) FROM PATIENTS WITH AIDS AND AT RISK FOR AIDS
GALLO, RC
论文数:
0
引用数:
0
h-index:
0
机构:
NCI, IMMUNOL BRANCH, BETHESDA, MD 20205 USA
GALLO, RC
SALAHUDDIN, SZ
论文数:
0
引用数:
0
h-index:
0
机构:
NCI, IMMUNOL BRANCH, BETHESDA, MD 20205 USA
SALAHUDDIN, SZ
POPOVIC, M
论文数:
0
引用数:
0
h-index:
0
机构:
NCI, IMMUNOL BRANCH, BETHESDA, MD 20205 USA
POPOVIC, M
SHEARER, GM
论文数:
0
引用数:
0
h-index:
0
机构:
NCI, IMMUNOL BRANCH, BETHESDA, MD 20205 USA
SHEARER, GM
KAPLAN, M
论文数:
0
引用数:
0
h-index:
0
机构:
NCI, IMMUNOL BRANCH, BETHESDA, MD 20205 USA
KAPLAN, M
HAYNES, BF
论文数:
0
引用数:
0
h-index:
0
机构:
NCI, IMMUNOL BRANCH, BETHESDA, MD 20205 USA
HAYNES, BF
PALKER, TJ
论文数:
0
引用数:
0
h-index:
0
机构:
NCI, IMMUNOL BRANCH, BETHESDA, MD 20205 USA
PALKER, TJ
REDFIELD, R
论文数:
0
引用数:
0
h-index:
0
机构:
NCI, IMMUNOL BRANCH, BETHESDA, MD 20205 USA
REDFIELD, R
OLESKE, J
论文数:
0
引用数:
0
h-index:
0
机构:
NCI, IMMUNOL BRANCH, BETHESDA, MD 20205 USA
OLESKE, J
SAFAI, B
论文数:
0
引用数:
0
h-index:
0
机构:
NCI, IMMUNOL BRANCH, BETHESDA, MD 20205 USA
SAFAI, B
WHITE, G
论文数:
0
引用数:
0
h-index:
0
机构:
NCI, IMMUNOL BRANCH, BETHESDA, MD 20205 USA
WHITE, G
FOSTER, P
论文数:
0
引用数:
0
h-index:
0
机构:
NCI, IMMUNOL BRANCH, BETHESDA, MD 20205 USA
FOSTER, P
MARKHAM, PD
论文数:
0
引用数:
0
h-index:
0
机构:
NCI, IMMUNOL BRANCH, BETHESDA, MD 20205 USA
MARKHAM, PD
[J].
SCIENCE,
1984,
224
(4648)
: 500
-
503
[6]
KELLEY JA, IN PRESS DRUG METAB
[7]
INHIBITION OF THE INVITRO INFECTIVITY AND CYTOPATHIC EFFECT OF HUMAN LYMPHOTROPHIC-T VIRUS "TYPE-III/LYMPHADENOPATHY-ASSOCIATED VIRUS (HTLV-III/LAV) BY 2',3'-DIDEOXYNUCLEOSIDES
MITSUYA, H
论文数:
0
引用数:
0
h-index:
0
MITSUYA, H
BRODER, S
论文数:
0
引用数:
0
h-index:
0
BRODER, S
[J].
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA,
1986,
83
(06)
: 1911
-
1915
[8]
THERMAL INACTIVATION AS A MEANS OF INHIBITING SERUM-ASSOCIATED DEAMINATION OF 9-BETA-D-ARABINOFURANOSYLADENINE IN TISSUE-CULTURE MEDIA
SCHWARTZ, PM
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV MICHIGAN, SCH MED, DEPT MICROBIOL, ANN ARBOR, MI 48104 USA
SCHWARTZ, PM
SHIPMAN, C
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV MICHIGAN, SCH MED, DEPT MICROBIOL, ANN ARBOR, MI 48104 USA
SHIPMAN, C
CARLSON, RH
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV MICHIGAN, SCH MED, DEPT MICROBIOL, ANN ARBOR, MI 48104 USA
CARLSON, RH
DRACH, JC
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV MICHIGAN, SCH MED, DEPT MICROBIOL, ANN ARBOR, MI 48104 USA
DRACH, JC
[J].
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY,
1974,
5
(03)
: 337
-
343
[9]
TYAGI AK, 1980, CANCER RES, V40, P4390
←
1
→